---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: VIP - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/vip
version: v1
---

# VIP - NCI

# VIP

This chemotherapy combination contains the drugs etoposide (VP-16), ifosfamide, and cisplatin (Platinol). Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the VIP combination:

|  |  |
| --- | --- |
| **V** | = [Etoposide](/about-cancer/treatment/drugs/etoposidephosphate) (VP-16) |
| **I** | = [Ifosfamide](/about-cancer/treatment/drugs/ifosfamide) |
| **P** | = [Cisplatin](/about-cancer/treatment/drugs/cisplatin) (Platinol) |

Each of the drugs in this combination is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to cancer.

## Use in Cancer

VIP
is used to treat:

- **[Testicular cancer](/Common/PopUps/popDefinition.aspx?id=445090&version=Patient&language=English)** that is [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English). It is often used in patients who cannot receive [bleomycin sulfate](/Common/PopUps/popDefinition.aspx?id=637625&version=Patient&language=English).

This combination may also be used with other drugs or
treatments or to treat other types of cancer.

## More About VIP

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759409) - Detailed scientific definition and other names for this drug.
